combining semaglutide with tirzepatide vs Tirzepatide: Which GLP-1 Is Right for You Combining Semaglutide and Tirzepatide: Evidence

Overall psychiatric safety Large analyses have not shown an overall increase in psychiatric adverse events with GLP-1 receptor agonists and some data suggest improvements in emotional eating and restrained eating behaviors

Liraglutide (Victoza) was approved in 2010, followed by Saxenda (for weight loss) in 2014.33 Semaglutide (Ozempic) was approved in 2017, Wegovy (for weight loss) in 2021, and Rybelsus (oral) shortly thereafter

Injection sites: Rotate between sites to prevent lipodystrophy (fat pad changes)

What are some possible reasons a patient with ASD might be a good candidate for a stimulant

Normal sensations include mild nausea or fullness, slight fatigue, changing appetite, minor digestive changes